Paracrine, Inc.

Our Science

Our Science

Our Science

Biologic Therapy Enabled via a Medical Device

Available at the Point-of-Care 

Biologic Therapy Enabled via a Medical Device

Available at the Point-of-Care

Biologic Therapy Enabled via a Medical Device

Available at the Point-of-Care 

Interrupt Multiple Components of "Vicious Cycle" in Chronic Wounds

Interrupt Multiple Components of "Vicious Cycle" in Chronic Wounds

Heterogeneous Cell Population Addresses the Common Underlying Pathology in Complex Conditions

 

A Single Pathophysiologic Mechanism is Not Sufficient

Interrupt Multiple Components of "Vicious Cycle" in Chronic Wounds

Heterogeneous Cell Population Addresses the Common Underlying Pathology in Complex Conditions


A Single Pathophysiologic Mechanism is Not Sufficient

Disease Modifying Therapy

Dynamically Respond to Local Environmental Cues by Releasing “Adipokines” 
Adipokines include >600 signaling molecules (proteins, peptides, hormones, and cytokines)  
Paracrine Signaling:  Local Cell-to-Cell Communications (“Cross-Talk”)

Disease Modifying Therapy

Dynamically Respond to Local Environmental Cues by Releasing “Adipokines” 
Adipokines include >600 signaling molecules 
(proteins, peptides, hormones, and cytokines)  
Paracrine Signaling:  Local Cell-to-Cell Communications (“Cross-Talk”)

Disease Modifying Therapy

Dynamically Respond to Local Environmental Cues 
by Releasing “Adipokines” 

Adipokines include >600 signaling molecules (proteins, peptides, hormones, and cytokines)  

Paracrine Signaling: 
Local Cell-to-Cell Communications (“Cross-Talk”)